Vitamin D and Alzheimer's disease: From an intriguing idea to a therapeutic option;Vitamine D et maladie d'Alzheimer: D'une curieuse idée à une possibilité de traitement

Biologie Aujourd'hui

Volumn 208, Issue 1, 2014, Pages 89-95

  Annweiler, Cédric ^a,b  

^a PRES UNAM   (France)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Biomarker; Older adults; Steroid hormone; Supplementation; Vitamin D

Indexed keywords

ACETYLCHOLINE; AMYLOID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; MEMANTINE; NEUROPROTECTIVE AGENT; VITAMIN D;

ALZHEIMER DISEASE; ANIMAL; ATROPHY; BRAIN; COMPLICATION; DEFICIENCY; DRUG COMBINATION; HUMAN; METABOLISM; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RAT; VITAMIN D DEFICIENCY;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ATROPHY; BRAIN; DRUG THERAPY, COMBINATION; HUMANS; MEMANTINE; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; RATS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84903268228     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2014005     Document Type: Article

References (51)

1. Aisen P.S., Pre-dementia Alzheimer's trials: overview. J Nutr Health Aging, 2010, 14, 294.
2. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P., Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron, 1995, 15, 961-973.
3. Annweiler C., Beauchet O., Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology, 2011, 37, 249-258.
4. Annweiler C., Beauchet O., Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D. Drugs Aging, 2012, 29, 81-91.
5. Annweiler C., Beauchet O., Vitamin D and cognition: recommendations for future trials. J Am Geriatr Soc, 2013, 61, 1049-1050.
6. Annweiler C., Allali G., Allain P., Bridenbaugh S., Schott A.M., Kressig R.W., Beauchet O., Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol, 2009, 16, 1083-1089.
7. Annweiler C., Schott A.M., Berrut G., Chauviré V., Le Gall D., Inzitari M., Beauchet O., Vitamin D and ageing: neurological issues. Neuropsychobiology, 2010 a, 62, 139-150.
8. Annweiler C., Schott A.M., Allali G., Bridenbaugh S.A., Kressig R.W., Allain P., Herrmann F.R., Beauchet O., Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010 b, 74, 27-32.
9. Annweiler C., Le Gall D., Fantino B., Beauchet O., Tucker K.L., Buell J.S., 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010 c, 75, 95.
10. Annweiler C., Schott A.M., Rolland Y., Blain H., Herrmann F.R., Beauchet O., Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 2010 d, 75, 1810-1816.
11. Annweiler C., Souberbielle J.C., Schott A.M., de Decker L., Berrut G., Beauchet O., Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil, 2011 a, 9, 259-267.
12. Annweiler C., Fantino B., Le Gall D., Schott A.M., Berrut G., Beauchet O., Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J Am Geriatr Soc, 2011 b, 59, 169-171.
13. Annweiler C., Rolland Y., Schott A.M., Blain H., Vellas B., Beauchet O., Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord, 2011 c, 32, 273-278.
14. Annweiler C., Fantino B., Parot E., Thiéry S., Gautier J., Beauchet O., Alzheimer's Disease-Input of vitamin D with memantine Assay: A double-blind randomized placebo-controlled trial (AD-IDEA Trial). Trials, 2011 d, 12, 230.
15. Annweiler C., Fantino B., Schott A.M., Krolak-Salmon P., Allali G., Beauchet O., Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol, 2012 a, 19, 1023-1029.
16. Annweiler C., Rolland Y., Schott A.M., Blain H., Vellas B., Herrmann F.R., Beauchet O., Higher vitamin D dietary intake is associated with lower risk of Alzheimer's disease: a 7-year follow-up. J Gerontol A Biol Sci Med Sci, 2012 b, 67, 1205-1211.
17. Annweiler C., Fantino B., Gautier J., Beaudenon M., Thiéry S., Beauchet O., Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J Am Geriatr Soc, 2012 c, 60, 793-795.
18. Annweiler C., Herrmann F.R., Fantino B., Brugg B., Beauchet O., Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn Behav Neurol, 2012 d, 25, 121-127.
19. Annweiler C., Montero-Odasso M., Hachinski V., Seshadri S., Bartha R., Beauchet O., Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol Nutr Food Res, 2013 a, 57, 267-276.
20. Annweiler C., Montero-Odasso M., Llewellyn D.J., Richard-Devantoy S., Duque G., Beauchet O., Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis, 2013 b, 37, 147-171.
21. Annweiler C., Llewellyn D.J., Beauchet O., Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis, 2013 c, 33, 659-674.
22. Annweiler C., Brugg B., Peyrin J.M., Bartha R., Beauchet O., Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol Aging, 2014, 35, 331-335.
23. Balion C., Griffith L.E., Strifler L., Henderson M., Patterson C., Heckman G., Llewellyn D.J., Raina P., Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology, 2012, 79, 1397-1405.
24. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., Porter N.M., Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci, 2001, 21, 98-108.
25. Brown J., Bianco J.I., McGrath J.J., Eyles D.W., 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett, 2003, 343, 139-143.
26. Burns J.M., Johnson D.K., Watts A., Swerdlow R.H., Brooks W.M., Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol, 2010, 67, 428-433.
27. Camicioli R.M., Kaye J.A., Brummel-Smith K., Recognition of neurologic diseases in geriatric inpatients. Acta Neurol Scand, 1998, 97, 265-270.
28. Cavalli A., Bolognesi M.L., Minarini A., Rosini M., Tumiatti V., Recanatini M., Melchiorre C., Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem, 2008, 51, 347-372.
29. Dean A.J., Bellgrove M.A., Hall T., Phan W.M., Eyles D.W., Kvaskoff D., McGrath J.J., Effects of vitamin D supplementation on cognitive and emotional functioning in young adults-a randomised controlled trial. PLoS One, 2011, 6, e25966.
30. Dubois B., Update on Alzheimer's diseases. Ann Pharm Fr, 2009, 67, 116-126.
31. Etgen T., Sander D., Bickel H., Sander K., Forstl H., Vitamin D deficiency, cognitive impairment and dementia: A systematic review and meta-analysis. Dement Geriatr Cogn Disord, 2012, 33, 297-305.
32. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D., New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab, 2002, 13, 100-105.
33. Gezen-Ak D., Dursun E., Ertan T., Hanagasi H., Gürvit H., Emre M., Eker E., Oztürk M., Engin F., Yilmazer S., Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med, 2007, 212, 275-282.
34. Holick M.F., Vitamin D deficiency. N Engl J Med, 2007, 357, 266-281.
35. Ibi M., Sawada H., Nakanishi M., Kume T., Katsuki H., Kaneko S., Shimohama S., Akaike A., Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology, 2001, 40, 761-771.
36. Ito S., Ohtsuki S., Nezu Y., Koitabashi Y., Murata S., Terasaki T., 1 α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS, 2011, 8, 20.
37. Johansson P., Almqvist E.G., Johansson J.O., Mattsson N., Andreasson U., Hansson O., Wallin A., Blennow K., Zetterberg H., Svensson J., Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease. PLoS One, 2013, 8, e81989.
38. Kalueff A.V., Tuohimaa P., Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care, 2007, 10, 12-19.
39. 3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis, 2009, 17, 703-717.
40. Moon M., Song H., Hong H.J., Nam D.W., Cha M.Y., Oh M.S., Yu J., Ryu H., Mook-Jung I., Vitamin D-binding protein interacts with Abeta and suppresses Abeta-mediated pathology. Cell Death Differ, 2013, 20, 630-638.
41. Oudshoorn C., Mattace-Raso F.U., van der Velde N., Colin E.M., van der Cammen T.J., Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord, 2008, 25, 539-543.
42. Perl D.P., Neuropathology of Alzheimer's disease. Mt Sinai J Med, 2010, 77, 32-42.
43. Przybelski R., Agrawal S., Krueger D., Engelke J.A., Walbrun F., Binkley N., Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int, 2008, 19, 1621-1628.
44. 3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin diabetic rats. Diabetologia, 1999, 42, 1308-1313.
45. 2 followed by intranasal insulin in Alzheimer's disease. J Alzheimers Dis, 2011, 26, 477-484.
46. Sokolow S., Luu S.H., Vinters H.V., Miller C.A., Gylys K.H. Glutamatergic (VGLUT1) synapses are not lost in Alzheimer's disease cerebral cortex, but preferentially accumulate amyloid-beta and p-tau pathology. Alzheimers Dement, 2010, 6, S243.
47. Sonnenberg J., Luine V.N., Krey L.C., Christakos S., 1,25- dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology, 1986, 118, 1433-1439.
48. Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R., McLachlan D.R., Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res, 1992, 13, 239-250.
49. Walton H.S., Dodd P.R., Glutamate-glutamine cycling in Alzheimer's disease. Neurochem Int, 2007, 50, 1052-1066.
50. Wang Y., Chiang Y.H., Su T.P., Hayashi T., Morales M., Hoffer B.J., Lin S.Z., Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology, 39, 2000, 873-880.
51. 3-Enriched Diet Correlates with a Decrease of Amyloid Plaques in the Brain of AbetaPP Transgenic Mice. J Alzheimers Dis, 2011, 25, 295-307.